![](https://srfcure.org/wp-content/uploads/2024/02/2.24-Nela.jpg)
Nearly 90% of those with scleroderma have Raynaud’s symptoms. This is why Raynaud’s can be a “red flag” that helps lead to diagnosis and treatment of scleroderma. And for Aneila, dx…
![](https://srfcure.org/wp-content/uploads/2024/01/2024-GregoryGordon-Headshot.png)
Dr. Gordon will have oversight over the SRF’s global clinical trial program CONQUEST and will contribute to the research program across the SRF portfolio San Francisco, CA (January 25, 2024)…
![](https://srfcure.org/wp-content/uploads/2023/02/SRF-complications-treatment-hero.jpg)
SAN FRANCISCO, December 19, 2023 — The Scleroderma Research Foundation (SRF), the nation’s largest non-profit funder of scleroderma research, today announced that the FDA has cleared its Investigational New Drug…